Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2020 Nov-Dec;14(6):2031-2038.
doi: 10.1016/j.dsx.2020.10.016. Epub 2020 Oct 21.

Clinical characteristics and short term outcomes after recovery from COVID-19 in patients with and without diabetes in Bangladesh

Affiliations
Comparative Study

Clinical characteristics and short term outcomes after recovery from COVID-19 in patients with and without diabetes in Bangladesh

Farhana Akter et al. Diabetes Metab Syndr. 2020 Nov-Dec.

Abstract

Background and aims: This study investigated the clinical manifestations, outcomes and long-term complications of COVID-19 inpatients in southern part of Bangladesh while emphasizing on individuals having diabetes.

Methods: A cross-sectional study was conducted for a sample of COVID-19 inpatients across four different hospitals of Bangladesh between April 1and June 30, 2020. Variation in clinical characteristics, contact history, comorbidities, treatment patterns, and immediate post COVID complications were investigated.

Results: There were 734 COVID-19 presentations in this study of which 19.8% of patients had diabetes and 76% of the COVID-19 patients were male. Among biochemical parameters, plasma glucose, D-dimer, and Troponin-I levels were significantly elevated amidst the cohort with diabetes. The frequency of patients requiring insulin increased threefold during infection with SARS CoV-2. 1.4% patients developed new onset of diabetes mellitus. A number of COVID-19 patients with diabetes have been suffering from complications post-recovery including pain, discomfort, and sleep disturbance.

Conclusion: Individuals with diabetes have experienced a severe manifestation of COVID-19 and post disease complications. Further in-depth studies focused on larger sample sizes are entailed to assess the relationships elaborately.

Keywords: Bangladesh; COVID-19; Comorbidities; Diabetes; Insulin.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest The authors would like to declare that there is no known contending financial interests or personal relationships that could affect the work reported in this paper.

Figures

Fig. 1
Fig. 1
Various treatments and medications of diabetic patients during covid-19. A) Percentage of the anti-diabetic medications used before and during covid-19. B) Frequency of different treatments and drugs during covid-19 C) Dose of insulin used during covid-19.

References

    1. Jin Y. Virology, epidemiology, pathogenesis, and control of COVID-19. Viruses. 2020;12(4):372. - PMC - PubMed
    1. Hussain A., Bhowmik B., do Vale Moreira N.C. Diabetes research and clinical practice; 2020. COVID-19 and diabetes: knowledge in progress; p. 108142. - PMC - PubMed
    1. Perrotta F. Severe respiratory SARS-CoV2 infection: does ACE2 receptor matter? Respir Med. 2020:105996. - PMC - PubMed
    1. Adhikari S.P. Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review. Infectious diseases of poverty. 2020;9(1):1–12. - PMC - PubMed
    1. Jalava K. First respiratory transmitted food borne outbreak? Int J Hyg Environ Health. 2020;226:113490. - PMC - PubMed

MeSH terms